Fda

Galway-based Atlantic Therapeutics raises €18m from existing backers

Company’s flagship product treats stress urinary incontinence which affects 1 in 3 women

US filmmaker faces trial in Italy after testifying in tainted blood scandal case

Kelly Duda faces fascist-era charge of ‘offending the honour or prestige’ of prosecutor

US man recovering after first-of-its-kind pig heart transplant

Patient with terminal heart disease implanted with genetically modified pig heart

Can antigen tests properly detect Omicron?

Could rapid antigen tests be missing some cases of the Omicron variant of Covid-19?

‘We aren’t afraid’: Mexican activists risk jail time to help Americans get abortions

Activists plan to post abortion pills to women in US as restrictions multiply across country

Pfizer oral Covid-19 pill gets US authorisation for at-home use

Ringaskiddy plant to play key role in manufacture of landmark treatment

Pfizer says Covid-19 pill almost 90% effective against severe infection

‘Staggering’ number of lives will be saved, says company’s chief scientific officer

Belfast-based Neurovalens secures funding for clinical trial

Company seeking to use technology to treat anxiety and PTSD

European regulators cast doubt on Biogen Alzheimer’s treatment

EMA vote deals a setback to controversial $56,000-a-year treatment

Merck’s Covid-19 pill secures green light from UK regulator

Antiviral drug hailed by experts as an important new tool to combat pandemic

Pfizer says its Covid vaccine is highly effective in children aged five to 11

Findings submitted to US regulatory authority

OneProjects secures $17m for groundbreaking heart scans

Advanced medical device delivers high-res images of beating heart in real time

Pfizer vaccine for children may be ready by end-November – White House adviser

FDA has scheduled time to review application for emergency use

Covid-19 antiviral pill halves risk of hospitalisation and death – Merck

Pharmaceuticals company developing twice-daily pill for patients diagnosed with virus

Covid booster dose gives 100% protection against severe infection – study

Johnson & Johnson study looks at impact of booster two months after original vaccination

Pfizer to apply for US vaccine approval for younger children in November

Application will feature children aged between six months and five years

MOST READ

1

First Look: Dún Laoghaire Baths are finally set to reopen. It’s a breathtaking sight

2

Best movie of all time: The world’s critics crown a new winner

3

Monaghan deaths: Victim may have been murdered by second man who was killed by car as he fled

4

Don’t cry for Seán Quinn – even if he cannot stop doing it for himself

5

IRA’s continued links to criminality should be reality check for Sinn Féin supporters

YOU MAY ALSO LIKE...

The Irish Times ePaper